Clinical Pharmacology of an Atrasentan and Docetaxel Regimen in Men with Hormone-Refractory Prostate Cancer

Islam R. Younis,Daniel J. George,Terence J. McManus,Herbert Hurwitz,Patricia Creel,Andrew J. Armstrong,Jing Jie Yu,Kristina Bacon,Gerald R. Hobbs,Cody J. Peer,William P. Petros

Clinical Pharmacology of an Atrasentan and Docetaxel Regimen in Men with Hormone-Refractory Prostate Cancer

2014

Islam R. Younis
Daniel J. George
Terence J. McManus
Herbert Hurwitz
Patricia Creel
Andrew J. Armstrong
Jing Jie Yu
Kristina Bacon
Gerald R. Hobbs
Cody J. Peer
William P. Petros

Purpose This study was conducted to evaluate potential pharmacokinetic interactions between docetaxel and atrasentan as part of a phase I/II clinical trial.

Keywords:

Oncology
Regimen
Clinical trial
Cancer
Hormone therapy
Clinical pharmacology
Atrasentan
Pharmacology
Prostate cancer
Internal medicine
Docetaxel
Medicine
Surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations